These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3489542)

  • 1. Sensitized (T6 x RFM)F1 donor B cells contribute to hypergammaglobulinemia and to poor primary responses in RFM mice with allogenic host versus graft disease.
    Hard RC; Benson LL
    Cell Immunol; 1986 Sep; 101(2):593-603. PubMed ID: 3489542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.
    Hard RC; Patel MR; Keller LM; Linna TJ
    Immunology; 1988 Mar; 63(3):457-64. PubMed ID: 3258280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS; Brede G; Tucker HS; Maloney M; Montour JL; Hard RC
    Infect Immun; 1983 Aug; 41(2):570-7. PubMed ID: 6135664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent difference in the roles of spleen and lymph nodes in the pathogenesis of host-versus-graft disease in murine parent/F1 chimeras.
    Hard RC; Benson LL; Keller LM
    Transplantation; 1987 Sep; 44(3):434-9. PubMed ID: 3498242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.
    Hard RC
    Clin Exp Immunol; 1975 Nov; 22(2):330-40. PubMed ID: 1082403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.
    Hard RC; Montour JL; Fuchs BA
    Clin Exp Immunol; 1995 May; 100(2):352-8. PubMed ID: 7743676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes in serum immunoglobulin levels in young RFM mice with host-versus-graft disease.
    Hard RC
    Immunology; 1980 Apr; 39(4):453-61. PubMed ID: 7380475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal immunopathology in murine host-versus-graft disease.
    Florquin S; Abramowicz D; de Heer E; Bruijn JA; Doutrelepont JM; Goldman M; Hoedemaeker P
    Kidney Int; 1991 Nov; 40(5):852-61. PubMed ID: 1762289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic studies of RFM mice which are susceptible to host versus graft disease following the perinatal inoculations of (T6 x RFM)F1 spleen cells and of T6T6 mice which are not.
    Hard RC; Cross SS; Brede G; Montour JL; Carter WH
    Clin Immunol Immunopathol; 1981 Sep; 20(3):427-35. PubMed ID: 6978788
    [No Abstract]   [Full Text] [Related]  

  • 12. Engraftment of allogeneic hematopoietic stem cells requires both inhibition of host-versus-graft responses and 'space' for homeostatic expansion.
    Laylor R; Dewchand H; Simpson E; Dazzi F
    Transplantation; 2005 Jun; 79(11):1484-91. PubMed ID: 15940036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.
    Ramos A; González M; López-Hoyos M; Carrió R; Merino J
    Immunology; 1996 Nov; 89(3):413-8. PubMed ID: 8958055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular fibrin deposits, hepatic infarcts and thrombocytopenia in parent/F mouse chimeras with host-versus-graft syndrome.
    Hard RC; Still WJ
    Am J Pathol; 1975 Apr; 79(1):131-46. PubMed ID: 1124797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease.
    Vandenabeele P; Abramowicz D; Berus D; Van der Heyden J; Grooten J; Donckier V; Hooghe-Peters EL; Goldman M; Fiers W
    J Immunol; 1993 May; 150(9):4179-87. PubMed ID: 8473756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody.
    Wissing M; Marchant A; Moser M; Flamand V; Leo O; Abramowicz D; Urbain J; Goldman M
    Clin Exp Immunol; 1991 Feb; 83(2):333-7. PubMed ID: 1825190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes.
    Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E
    Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.